Clinical Trial Update: Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating safety and efficacy of a Y-shape pegylated somatropin in children with growth hormone deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Y-shape Pegylated Somatropin (pegylated somatropin)

Snippet

Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Conditions: Growth Hormone Deficiency | Phase 2, Phase 3 | Status: COMPLETED